Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/1001395.pdf
Reference13 articles.
1. Püchler K, Laeis P, Stumpe KO . Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist J Hypertens 2001 19 (Suppl 1): S41–S48
2. Thurman PA . Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy Cardiology 1999 91 (Suppl 1): 3–7
3. Birkenhager WH, de Leeuw PW . Non-peptide angiotensin type I receptor antagonists in the treatment of hypertension J Hypertens 1999 17: 873–881
4. Gallagher M . Angiotensin II antagonists lead the way in hypertension management Inpharm 1998 1143: 13–15
5. De Leeuw PW . How do angiotensin II receptor antagonists affect blood pressure? Am J Cardiol 1999 84: 5K–6K
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coupling of synchronous fluorescence spectroscopy with derivative amplitude outcomes for simultaneous determination of metoprolol succinate and olmesartan medoxomil in combined pharmaceutical preparation: Application in spiked human plasma;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-06
2. Pharmacokinetics and Bioequivalence Evaluation of 2 Olmesartan Medoxomil and Amlodipine Besylate Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions;Clinical Pharmacology in Drug Development;2022-03-15
3. Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients;The Journal of Clinical Hypertension;2018-02
4. Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control;High Blood Pressure & Cardiovascular Prevention;2017-06-12
5. Management of Hypertension Using Olmesartan Alone or in Combination;Cardiology and Therapy;2017-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3